Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 83633 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 156906 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 169495 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 274691 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 477655 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 1971415 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | Peak area normalized | female | diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | Peak area normalized | female | normoglycemic | Neuropathy | |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | Peak area normalized | male | diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | Peak area normalized | male | diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | Peak area normalized | male | pre-diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | Peak area normalized | male | pre-diabetic | no neuropathy |